Why the Japara (ASX:JHC) share price is rocketing 23% in morning trade

The Japara Healthcare Ltd (ASX: JHC) share price is rocketing 23% higher today following a significant announcement. We take a closer look.

A drawing of a rocket follows a chart up, indicating share price lift

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Japara Healthcare Ltd (ASX: JHC) share price is rocketing in early-morning trade following the announcement of a takeover offer.

At the time of writing, the aged care provider's shares are swapping hands for 98.5 cents, up 23.1%.

Details of the offer

Investors are driving Japara shares higher after digesting the company's latest release.

In its announcement, Japara advised it has received a takeover proposal from Little Company of Mary Health Care Ltd (Calvary).

Founded in 1885, Little Company of Mary Health Care (also known as Calvary Health Care) provides community and aged care services. The group operates 14 public and private hospitals, 17 retirement and aged care facilities, and a number of community care centres throughout Australia.

The notice is an unsolicited, indicative, conditional, and non-binding proposal. Calvary plans to acquire 100% of the shareholding in Japara by way of a Scheme of Arrangement.

The indicative cash price offered to Japara shareholders is listed as $1.04 per share.

The company noted that the offer price takes into account that no dividends, distributions, or reductions in capital are paid. In addition, no material changes may occur from the date of the takeover notice. This is to ensure that the business does not significantly change in value from what Calvary has offered.

For the proposal to move forward, Japara would need to meet a number of conditions. This includes completion of due diligence, negotiation and executing the scheme arrangement, and unanimous recommendation by the board.

Japara management stated that it has not formed and view and will look into the offer along with business continuity. Trading conditions are expected to improve, and the group is waiting to hear the Australian federal government's response to the Royal Commission next month.

The Royal Commission looked into aged care quality and safety in October 2018. In March this year, the final report was released, listing 148 recommendations.

Lastly, Japara advised that it will update shareholders and the ASX in due course of the board's outcome.

About the Japara share price

The Japara share price has gained 60% in the past 12 months, and is up close to 30% year-to-date.

On valuation grounds, Japara commands a market capitalisation of around $213 million, with 267.2 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »